Fox Run Management, L.L.C. Acadia Pharmaceuticals Inc Transaction History

Fox Run Management, L.L.C.

  • $517 Million
  • Q2 2024

A detailed history of Fox Run Management, L.L.C. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 20,302 shares of ACAD stock, worth $300,266. This represents 0.06% of its overall portfolio holdings.

Number of Shares
20,302
Holding current value
$300,266
% of portfolio
0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$14.62 - $18.42 $296,815 - $373,962
20,302 New
20,302 $329,000
Q3 2023

Nov 07, 2023
BUY
$20.84 - $33.47 $489,260 - $785,775
23,477 New
23,477 $489,000
Q1 2023

May 12, 2023
BUY
$16.32 - $20.92 $1.04 Million - $1.33 Million
63,707 New
63,707 $1.2 Million
Q3 2022

Nov 07, 2022
BUY
$14.11 - $18.27 $68,334 - $88,481
4,843 Added 48.06%
14,920 $244,000
Q2 2022

Aug 12, 2022
SELL
$13.01 - $27.22 $182,439 - $381,706
-14,023 Reduced 58.19%
10,077 $142,000
Q1 2022

May 10, 2022
BUY
$20.94 - $27.5 $504,654 - $662,750
24,100 New
24,100 $584,000
Q4 2021

Feb 09, 2022
SELL
$16.79 - $27.09 $201,933 - $325,811
-12,027 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$15.78 - $24.77 $14,991 - $23,531
-950 Reduced 7.32%
12,027 $200,000
Q2 2021

Aug 05, 2021
BUY
$19.4 - $27.42 $251,753 - $355,829
12,977 New
12,977 $317,000
Q3 2020

Oct 29, 2020
SELL
$36.42 - $57.0 $253,410 - $396,606
-6,958 Closed
0 $0
Q2 2020

Jul 31, 2020
BUY
$39.26 - $52.73 $273,171 - $366,895
6,958 New
6,958 $334,000
Q4 2019

Feb 14, 2020
SELL
$36.21 - $51.4 $448,641 - $636,846
-12,390 Closed
0 $0
Q3 2019

Oct 15, 2019
BUY
$22.22 - $44.01 $275,305 - $545,283
12,390 New
12,390 $446,000
Q3 2018

Oct 05, 2018
SELL
$13.03 - $21.81 $336,460 - $563,177
-25,822 Closed
0 $0
Q2 2018

Jul 17, 2018
BUY
$15.07 - $22.34 $389,137 - $576,863
25,822 New
25,822 $394,000

Others Institutions Holding ACAD

# of Institutions
288
Shares Held
161M
Call Options Held
723K
Put Options Held
257K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email